We could all use extra time in the morning. Because I have rosacea, I can have redness and irritation. My makeup can cover it, but applying so much makeup takes time and isn’t a look that I like.
Breaking up with your makeup can be a great way to streamline your beauty routine and gain a few extra minutes each morning! For instance, on a bad skin day, I typically apply lotion, a redness canceling primer, a redness canceling spot treatment, a full coverage foundation, concealer, and powder. By treating my rosacea with the help of a doctor, I can get that routine down to a simple tinted moisturizer, and concealer for my undereye circles!
If you’re like me and have a lot of redness from rosacea, talk to your dermatologist about a product like Mirvaso® (brimonidine) topical gel, 0.33%*, an FDA-approved treatment for the persistent facial redness of rosacea. There are options to help you overcome tough skin days and each person’s rosacea is different, so definitely talk with a doctor about what might be right for you!
And don’t forget to head over to the Break Up with Your Makeup site to learn more about possible treatments and enter for a chance to win an all-expense paid trip to the Fall 2015 New York Film Festival by sharing a no makeup selfie!
Sponsored Post: This post is part of the Break Up with Your Makeup program sponsored by Galderma Laboratories, L.P. You should discuss any medications with your physician, but I do think it is a great idea to visit a dermatologist for a treatment plan that is right for you!
Important Safety Information – Mirvaso® Gel*
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha-2 adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin-burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. MIRVASO Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit WWW.FDA.GOV/MEDWATCH or call 1-800-FDA-1088
All trademarks are the property of their respective owners.